Search
HTL Announces Its Incubator's Equity Investment In GelMEDIX, An Early-Stage Biotech Aiming At Revolutionizing Ocular And Regenerative Therapies
BioConnects New England and LabCentral Ignite Announce Partnership
Cambridge, Massachusetts (4/19/2022) -…
Q&A with Ignite Golden Ticket Winner: Nanopath Puts Spotlight on Women’s Health
LabCentral recently announced the two winners of…
LabCentral Ignite Golden Ticket Spotlight: Harmony – A New Take on Baby Formula
The Ignite Golden Ticket program awards companies…
PRIDE Q&A WITH NATHAN HIGGINSON-SCOTT, CTO AND SVP OF DRUG CREATION AT SEISMIC THERAPEUTIC!
For the month of June, we'll be…
Pride Q&A with Gerry Deshycka, Research Associate at Cerberus Therapeutics
For the month of June, we'll be…